Stanford scientists developed a novel strategy that uses resting-state functional connectivity magnetic resonance imaging (rs-fMRI) to determine whether a person will respond to treatment for depression.
Stanford researchers develop a surgical technique to access the optical nerve head from tunneling through the suprachoroidal space (SCS) for drug delivery applications.
A Stanford inventor has developed a soft grommet/eyelet to load share and prevent suture pull-through of the repair stitch and a device to pass the eyelet.
Stanford researchers have developed a compact, scalable electronic readout that can multiplex 24 or more fast outputs of each 6x4 SiPM array to only 1 timing channel per detector layer unit.
Stanford scientists developed a comprehensive, minimally invasive, dual-catheter pulsed field device that utilizes a rapid and simple integrated mapping/ablation strategy for the treatment of Atrial Fibrillation.
Researchers at Stanford previously described a method under Stanford Docket S17-020 for introducing a large number of gene edits in parallel, termed Multiplexed Accurate Genome Editing with Short, Trackable, Integrated Cellular barcodes (MAGESTIC).
Researchers at Stanford and UCSF have discovered a strong association between serious, potentially fatal, delayed hypersensitivity reactions that occur in a subset of patients exposed to IL-1/IL-6 inhibitors and HLA-DRB1*15 alleles that are common across ancestries.
Researchers at Stanford and the European Molecular Biology Laboratory (EMBL) have discovered an improved embodiment of bacterial retron-based CRISPR gene editing in mammalian cells.
Stanford researchers have developed a geometric deep learning based novel method to aid in identification and discovery of novel drug scaffolds as well as to optimize known scaffolds, as a means to combat the major challenge in drug discovery.